{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:41:37Z","timestamp":1778830897362,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prro.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:08:28Z","timestamp":1756454908000},"page":"e397-e403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiation Recall Dermatitis Following Capivasertib Administration"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4151-1112","authenticated-orcid":false,"given":"Yuhao","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian W.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Kobrinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.04.004_bib0001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.04.004_bib0002","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.seminoncol.2022.04.001","article-title":"Radiation recall dermatitis: A review of the literature","volume":"49","author":"Bhangoo","year":"2022","journal-title":"Semin Oncol"},{"key":"10.1016\/j.prro.2025.04.004_bib0003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2014.08.030","article-title":"Radiation-recall dermatitis with the everolimus\/exemestane combination ten years after adjuvant whole-breast radiotherapy","volume":"112","author":"Ioannidis","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.04.004_bib0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clindermatol.2014.04.001","article-title":"Locus minoris resistentiae: An old but still valid way of thinking in medicine","volume":"32","author":"Lo Schiavo","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0005","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0190-9622(82)80099-6","article-title":"Dermatitis in loco minoris resistentiae","volume":"6","author":"Zuehlke","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/120347540200600603","article-title":"Histopathologic features seen with radiation recall or enhancement eruptions","volume":"6","author":"Smith","year":"2002","journal-title":"J Cutan Med Surg"},{"issue":"3 Pt 2","key":"10.1016\/j.prro.2025.04.004_bib0007","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/jid.2011.411","article-title":"Ionizing radiation: the good, the bad, and the ugly","volume":"132","author":"Ryan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103527","article-title":"Radiation recall reactions: An oncologic enigma","volume":"168","author":"McKay","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prro.2025.04.004_bib0009","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/028418699432653","article-title":"Radiation recall\u2013another call with tamoxifen","volume":"38","author":"Bostrom","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.04.004_bib0010","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-23-0354","article-title":"A phase II study of durvalumab for Bacillus Calmette-Guerin (BCG) unresponsive urothelial carcinoma in situ of the bladder","volume":"29","author":"Li","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2025.04.004_bib0011","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clbc.2013.12.011","article-title":"Radiation recall reaction with letrozole therapy in breast cancer","volume":"14","author":"Foster","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.prro.2025.04.004_bib0012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0140-6736(92)92460-W","article-title":"Radiation recall induced by tamoxifen","volume":"340","author":"Parry","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.04.004_bib0013","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1075-122X.2004.21222.x","article-title":"Tamoxifen-induced radiation recall dermatitis","volume":"10","author":"Singer","year":"2004","journal-title":"Breast J"},{"key":"10.1016\/j.prro.2025.04.004_bib0014","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1684\/ejd.2018.3295","article-title":"Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with nivolumab","volume":"28","author":"Rouyer","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamadermatol.2015.5366","article-title":"Radiation recall dermatitis with concomitant dabrafenib and pazopanib therapy","volume":"152","author":"Haraldsdottir","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0016","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2009.04.033","article-title":"Radiation recall dermatitis induced by erlotinib","volume":"61","author":"Dauendorffer","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0017","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12282-013-0462-6","article-title":"Radiation recall dermatitis induced by trastuzumab","volume":"23","author":"Moon","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.prro.2025.04.004_bib0018","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1365-4632.2012.05788.x","article-title":"Radiation recall dermatitis and pneumonitis induced by trastuzumab (Herceptin(R))","volume":"53","author":"Lee","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.prro.2025.04.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/307894","article-title":"Radiation recall reaction induced by adjuvant trastuzumab (herceptin)","volume":"2009","author":"Chung","year":"2009","journal-title":"Case Rep Med"},{"key":"10.1016\/j.prro.2025.04.004_bib0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clon.2009.03.003","article-title":"Trastuzumab-induced radiation recall dermatitis\u2013first reported case","volume":"21","author":"Shrimali","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2025.04.004_bib0021","article-title":"Radiation recall dermatitis with abemaciclib developing a year after radiotherapy","volume":"3","author":"Dasgupta","year":"2021","journal-title":"Curr Prob Cancer-C R"},{"key":"10.1016\/j.prro.2025.04.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100939","article-title":"Enhanced toxicity with CDK 4\/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature","volume":"14","author":"David","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.prro.2025.04.004_bib0023","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.canrad.2019.01.005","article-title":"Radiation recall syndrome in a patient with breast cancer, after introduction of everolimus","volume":"23","author":"Visy","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2025.04.004_bib0024","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.02.070","article-title":"Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: Analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"72","author":"Haffty","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.04.004_bib0025","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.04.004_bib0026","unstructured":"Are you comfortable combining palliative radiotherapy with capivasertib\/fulvestrant?: The mednet; 2024. Available from: https:\/\/www.themednet.org\/question\/20457. Accessed May 21, 2025."},{"key":"10.1016\/j.prro.2025.04.004_bib0027","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S1470-2045(23)00534-X","article-title":"International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations","volume":"25","author":"Meattini","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002500102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002500102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:42:00Z","timestamp":1756456920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187985002500102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S187985002500102X"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.04.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Recall Dermatitis Following Capivasertib Administration","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}